Proof-of-concept Study With NVDX3 for Treatment of Distal Radius Fractures.
Status:
Active, not recruiting
Trial end date:
2025-12-20
Target enrollment:
Participant gender:
Summary
Prospective, single arm, monocentric clinical study to test NVDX3 in patients suffering from
distal radius fracture. NVDX3 will be implanted during a single surgical intervention.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Novadip Biosciences
Collaborators:
Data Investigation Company Europe (DICE) PrimeVigilance